Gender Bias in U.S. Pediatric Growth Hormone Treatment

Growth hormone (GH) treatment of idiopathic short stature (ISS), defined as height <−2.25 standard deviations (SD), is approved by U.S. FDA. This study determined the gender-specific prevalence of height <−2.25 SD in a pediatric primary care population, and compared it to demographics of U.S....

Descripción completa

Detalles Bibliográficos
Autores principales: Grimberg, Adda, Huerta-Saenz, Lina, Grundmeier, Robert, Ramos, Mark Jason, Pati, Susmita, Cucchiara, Andrew J., Stallings, Virginia A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650610/
https://www.ncbi.nlm.nih.gov/pubmed/26057697
http://dx.doi.org/10.1038/srep11099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650610/
https://www.ncbi.nlm.nih.gov/pubmed/26057697
http://dx.doi.org/10.1038/srep11099

Ejemplares similares